This is a paid press release. Contact the press release distributor directly with any inquiries.

Vanda Pharmaceuticals Announces Participation in the 2026 Citizens Life Sciences Conference

PR Newswire

Fri, February 27, 2026 at 6:35 AM GMT+9 1 min read

In this article:

VNDA

+3.86%

WASHINGTON, Feb. 26, 2026 /PRNewswire/ – Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in the 2026 Citizens Life Sciences Conference in Miami on Wednesday, March 11, 2026. A corporate presentation is scheduled for 2:15 p.m. Eastern Time.

Vanda Logo (PRNewsfoto/Vanda Pharmaceuticals Inc.)

The corporate presentation given at the Citizens Life Sciences Conference may be accessed live on Vanda’s corporate website, www.vandapharma.com. Investors should click on the Investors tab and follow the link under Recent Events. Investors are advised to go to the conference website at least 15 minutes early to register, download, and install any necessary software or presentations. A link to the archived conference will be available on Vanda’s website for a period of approximately 30 days.

About Vanda Pharmaceuticals Inc.

Vanda is a leading global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com and follow us on X @vandapharma.

**Corporate Contact:

**Kevin Moran
Senior Vice President, Chief Financial Officer and Treasurer
Vanda Pharmaceuticals Inc.
202-734-3400
pr@vandapharma.com

Jim Golden / Jack Kelleher / Dan Moore
Collected Strategies
VANDA-CS@collectedstrategies.com

Cision

View original content to download multimedia:

Terms and Privacy Policy

Privacy Dashboard

More Info